Equity Research, Broker Reports, and media content on Oxford BioMedica plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Oxford BioMedica plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Oxford BioMedica plc

Company Profile

  • Personnel
  • John Dawson, CEO
  • Stuart Paynter, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Oxford BioMedica plc. We currently have 181 research reports from 8 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 357/899p
  • Daily Volume: N/A
  • Daily Liquidity: (0.18%)
  • # Shares: 82.1m
  • Market Cap: £701.8m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
23Nov20 08:47 RNS OXB notes AZD1222 met primary efficacy endpoint
23Nov20 07:00 RNS Non-Executive Director Appointment
09Nov20 07:00 RNS-R OXB and PhoreMost enter gene therapy collaboration
02Nov20 09:02 RNS Total Voting Rights
30Oct20 07:00 RNS Axovant update on AXO-Lenti-PD and virtual R&D day
23Oct20 10:27 RNS Director Purchase
12Oct20 17:38 RNS Holding(s) in Company
  • Frequency of research reports


  • Research reports on

    Oxford BioMedica plc

  • Providers covering

    Oxford BioMedica plc